Type 1 Diabetes

>

Latest News

US FDA logo in black over a white background. | Credit: US Food and Drug Administration
FDA Committee Casts Negative Vote on Sotagliflozin in Type 1 Diabetes

November 2nd 2024

The 11 to 3 vote against the benefit-risk profile of sotagliflozin comes with less than 2 months to go until the December 20, 2024 PDUFA date.

HCPLive Endocrinology Month in Review September 2024 thumbnail
Endocrinology Month in Review: September 2024

October 6th 2024

US FDA logo in black over a white background. | Credit: US Food and Drug Administration
FDA Clears Eversense 365, Marking First 1-Year CGM Option in Diabetes

September 18th 2024

HCPLive Endocrinology Month In Review August 2024
Endocrinology Month in Review: August 2024

September 10th 2024

Brian Callaghan, MD, MS | Credit: Michigan Medicine
Study Finds Diabetes Complications and Mental Health Disorders Are a 2-Way Street

August 27th 2024

<1
...
7891011
© 2024 MJH Life Sciences

All rights reserved.